Microbot Medical Heads Into Holiday Break With MBOT Under Pressure After LIBERTY Concerns
Microbot Medical shares fell 3.93% to $1.71 Friday, ending the week down 7.6%, despite the company reporting higher second-quarter revenue and more than doubling accounts for its LIBERTY robotic system. The stock dropped after White Diamond Research, holding a short position, questioned LIBERTY’s commercial prospects. Microbot scheduled an investor call to address the claims. U.S. markets will be closed Monday for Memorial Day.